CoChat

Defining the earliest pathological changes of Alzheimer's disease

Open access
C. Vickers, James, Mitew, Stan, Woodhouse, Adele, M. Fernandez-Martos, Carmen, T. Kirkcaldie, Mathew, J. Canty, Alison, H. McCormack, Graeme, E. King, Anna · 2016 · Current Alzheimer Research
Cited by 110

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

The prospects for effectively treating well-established dementia, such as Alzheimer's disease (AD), are slim, due to the destruction of key brain pathways that underlie higher cognitive function. There has been a substantial shift in the field towards detecting conditions such as AD in their earliest stages, which would allow preventative or therapeutic approaches to substantially reduce risk and/or slow the progression of disease. AD is characterized by hallmark pathological changes such as extracellular Aβ plaques and intracellular neurofibrillary pathology, which selectively affect specific subclasses of neurons and brain circuits. Current evidence indicates that Aβ plaques begin to form many years before overt dementia, a gradual and progressive pathology which offers a potential target for early intervention. Early Aβ changes in the brain result in localized damage to dendrites, axonal processes and synapses, to which excitatory synapses and the processes of projection neurons are highly vulnerable. Aβ pathology is replicated in a range of transgenic models overexpressing mutant human familial AD genes (e.g. APP and presenilin 1). Studying the development of aberrant regenerative and degenerative changes in neuritic processes associated with Aβ plaques may represent the best opportunity to understand the relationship between the pathological hallmarks of AD and neuronal damage, and to develop early interventions to prevent, slow down or mitigate against Aβ pathology and/or the neuronal alterations that leads to cognitive impairment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/1567205013666151218150322

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 110

Metadata

Authors
C. Vickers, J., Mitew, S., Woodhouse, A., M. Fernandez-Martos, C., T. Kirkcaldie, M., J. Canty, A., H. McCormack, G., & E. King, A.
Venue
Current Alzheimer Research
Published
2016-02-12
Volume
13
Issue
3
Pages
281-287
ISSN
1567-2050 (ISSN-L)
OpenAlex
W2221305104
Cited by
110
References
22
FWCI
2.58
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Defining the earliest pathological changes of Alzheimer's disease. https://app.cochat.ai/papers/10.2174/1567205013666151218150322
The paper
C. Vickers, J., Mitew, S., Woodhouse, A., M. Fernandez-Martos, C., T. Kirkcaldie, M., J. Canty, A., H. McCormack, G., & E. King, A. (2016). Defining the earliest pathological changes of Alzheimer's disease. Current Alzheimer Research. https://doi.org/10.2174/1567205013666151218150322

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.